Homology Medicines Inc
F:35H
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Homology Medicines Inc
F:35H
|
US |
|
Abivax SA
NASDAQ:ABVX
|
FR |
|
S
|
Schroder European Real Estate Investment Trust PLC
JSE:SCD
|
UK |
|
G
|
Galapagos NV
SWB:GXEA
|
BE |
|
H
|
Haseko Corp
F:HS6
|
JP |
|
T
|
TUI AG
F:TUI1
|
DE |
|
B
|
BYD Co Ltd
XMUN:BY6A
|
CN |
|
B
|
BYD Co Ltd
XBER:BY6
|
CN |
|
B
|
BYD Co Ltd
XMUN:BY6
|
CN |
|
W
|
Westwater Resources Inc
F:UCCP
|
US |
|
Hacksaw AB
F:51R
|
SE |
|
U
|
United Labels AG
DUS:ULC
|
DE |
|
C
|
Carlsberg A/S
OTC:CABGY
|
DK |
|
BYD Co Ltd
F:BY6A
|
CN |
Wall St Price Targets
35H Price Targets Summary
Homology Medicines Inc
According to Wall Street analysts, the average 1-year price target for
35H is 14.12 EUR with a low forecast of 9.81 EUR and a high forecast of 20.4 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 35H's stock price target?
Price Target
14.12
EUR
According to Wall Street analysts, the average 1-year price target for
35H is 14.12 EUR with a low forecast of 9.81 EUR and a high forecast of 20.4 EUR.